Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F de Man

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
JAMA Cardiology|May 22, 2019
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT TrialRosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
International Journal of Cardiology|August 30, 2014
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registryHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA studyMarlies M Kok, Clemens von Birgelen, Ming Kai Lam, et al.
International Journal of Cardiology|May 27, 2018
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPTPaolo Zocca, Marlies M Kok, Liefke C van der Heijden, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 19, 2019
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes studyEline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2014
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcomeHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Journal of Cardiology|August 2, 2016
Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERSJennifer Huisman, Liefke C van der Heijden, Marlies M Kok, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 8, 2014
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trialMing Kai Lam, Kenneth Tandjung, Hanim Sen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2017
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPTPaolo Zocca, Liefke C van der Heijden, Marlies M Kok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 30, 2013
Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trialKenneth Tandjung, Mounir W Z Basalus, Hanim Sen, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
JAMA Cardiology|May 22, 2019
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT TrialRosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
International Journal of Cardiology|August 30, 2014
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registryHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA studyMarlies M Kok, Clemens von Birgelen, Ming Kai Lam, et al.
International Journal of Cardiology|May 27, 2018
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPTPaolo Zocca, Marlies M Kok, Liefke C van der Heijden, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 19, 2019
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes studyEline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2014
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcomeHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Journal of Cardiology|August 2, 2016
Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERSJennifer Huisman, Liefke C van der Heijden, Marlies M Kok, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 8, 2014
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trialMing Kai Lam, Kenneth Tandjung, Hanim Sen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2017
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPTPaolo Zocca, Liefke C van der Heijden, Marlies M Kok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 30, 2013
Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trialKenneth Tandjung, Mounir W Z Basalus, Hanim Sen, et al.
Pageof 6